Concepedia

Janson Trieu

JT

5

Publications

159

Citations

5

H-Index

2013

Active since

Affiliations

Johns Hopkins University(Current)

Chang Gung University

Keelung Chang Gung Memorial Hospital

Korea University Medical Center

Janson Trieu is an author at Johns Hopkins University specializing in medicine, immunotherapy, and immunology.

ORCID

Top concepts

Publications per year

2013–2022

5

Publications

5

Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8+ T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ

Ruey-Shyang Soong, Liwen Song, Janson Trieu et al. · Clinical Cancer Research · 2014 · 53 citations · Full text

Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma

Kyrillus S. Shohdy, Dario Martin Villamar, Yen Cao et al. · British Journal of Cancer · 2022 · 38 citations · Full text

, , +9

Xenogeneic Human p53 DNA Vaccination by Electroporation Breaks Immune Tolerance to Control Murine Tumors Expressing Mouse p53

Ruey-Shyang Soong, Janson Trieu, Sung Yong Lee et al. · PLoS ONE · 2013 · 34 citations · Full text

, , +15

Direct T Cell Activation via CD40 Ligand Generates High Avidity CD8+ T Cells Capable of Breaking Immunological Tolerance for the Control of Tumors

Ruey-Shyang Soong, Liwen Song, Janson Trieu et al. · PLoS ONE · 2014 · 24 citations · Full text

, , +18

Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy

Luke Peng, Amol Narang, Carol Gergis et al. · Urologic Oncology Seminars and Original Investigations · 2018 · 10 citations

Rows per page

1–5 of 5